Early-demographic dividend vs Oman: Prevalence of hypertension
Early-demographic dividend
33.8%
in 2019
Oman
45.6%
in 2019
Early-demographic dividend rank
24th
Oman rank
21st
Prevalence of hypertension over time
- Early-demographic dividend
- Oman
How they compare
Oman currently reports 45.6% against 33.8% in Early-demographic dividend, a difference of 11.8%.
That makes Oman's figure about 1.3 times Early-demographic dividend's.
Across all 30 years both countries report, Oman has been ahead every year.
Early-demographic dividend ranks 24th and Oman ranks 21st of 43 groups.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Early-demographic dividend | Oman | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 31.6% | 45.2% | 13.6% | Oman |
| 2000s | 33.3% | 46.8% | 13.6% | Oman |
| 2010s | 33.8% | 46.4% | 12.6% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, Early-demographic dividend or Oman?
- Oman, at 45.6% against 33.8% in Early-demographic dividend as of 2019.
- What is the difference in prevalence of hypertension between Early-demographic dividend and Oman?
- 11.8%, with Oman ahead.
- How many years of comparable data are there for Early-demographic dividend and Oman?
- 30 years are reported by both, from 1990 to 2019.
- How do Early-demographic dividend and Oman rank globally for prevalence of hypertension?
- Early-demographic dividend ranks 24th and Oman ranks 21st of 43 groups.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension (% of adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.